About: Documentation of pediatric drug safety in manufacturers' product monographs: a cross-sectional evaluation of the canadian compendium of pharmaceuticals and specialities

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Documentation of pediatric drug safety in manufacturers' product monographs: a cross-sectional evaluation of the canadian compendium of pharmaceuticals and specialities Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

scientific article published on 01 January 2008

Attributes	Values
rdf:type	Item
description	wetenschappelijk artikel (nl) article scientifique (publié 2008) (fr) наукова стаття, опублікована в січні 2008 (uk) im Jahr 2008 veröffentlichter wissenschaftlicher Artikel (de) artículu científicu espublizáu en xineru de 2008 (ast) artikull shkencor i botuar më 01 janar 2008 (sq) scientific article published on 01 January 2008 (en)
publication date	wds:Q81209124-7EACA4CD-D851-40E5-BF78-7A9F7BE6F291
publication date	2008-01-01 00:00:00Z (xsd:dateTime)
exact match	wds:Q81209124-6FDE2377-1BB7-4C69-B567-BC74B1174838
exact match	https://scigraph.springernature.com/pub.10.2165/00148581-200810030-00007
cites work	wds:Q81209124-069726AF-5515-4EF7-B39D-E3C28A8DF4A7 wds:Q81209124-4E8C7506-EEDE-42CC-9412-87F6A2878BC3 wds:Q81209124-5C3BCC3F-79CE-4668-80DA-A9EBEC2C8E2F wds:Q81209124-6F10552D-B356-4AE1-9840-702C993EF06B wds:Q81209124-8CBA1797-9A7C-4FA0-8C31-3A1195FED428 wds:Q81209124-8DF710CF-FB40-4E20-8BD6-1D126672F665 wds:Q81209124-99BD8189-A8A6-49E4-86C9-01DA0C6DFE6D wds:Q81209124-A055C4BE-F61A-4600-B0BF-294748E0F243 wds:Q81209124-A5E622A7-5210-440A-AFF4-16E7BECC8569 wds:Q81209124-A9E60ACC-AB14-44CF-BB01-A89106974151 wds:Q81209124-AD2B1291-FFD1-4656-BF67-B242F1D6E418 wds:Q81209124-B0488C70-AA9E-4F6B-8342-F65D92103CD8 wds:Q81209124-BA704CE3-BEAB-423C-B3DD-1C8805B28805 wds:Q81209124-BE234E53-5C0A-43F9-89D7-C9F00696849A wds:Q81209124-C3319AF3-4D43-48A0-9400-6AEFF89A025B wds:Q81209124-CA893260-1963-4AFA-A13B-8CF623F2D863 wds:Q81209124-D096DB01-48D8-465F-93A2-0BD36AB19372 wds:Q81209124-E88FD9EB-7328-4632-B56D-014EFE77B9AA wds:Q81209124-E90DA137-8924-4C46-89C4-88D7E1013854 wds:Q81209124-F28C97D9-95E6-4782-99FD-69E634BB8208 wds:Q81209124-F905DF90-DE76-46E2-9D4D-A0EA3088C532
cites work	Incidence of adverse drug reactions in paediatric in/out-patients: a systematic review and meta-analysis of prospective studies Pediatric drug labeling: improving the safety and efficacy of pediatric therapies Unlicensed and off-label drug use in children: implications for safety Drug discovery in jeopardy Developmental pharmacology--drug disposition, action, and therapy in infants and children Off-label and unlicensed prescribing for newborns and children in different settings: a review of the literature and a consideration about drug safety Dilution of intravenous N-acetylcysteine as a cause of hyponatremia Off-label uses of drugs in children. The use of unlicensed and off-label medicines in the neonate A literature review on off-label drug use in children Paediatric medicines research in the UK: how to move forward? A prospective questionnaire assessment of attitudes and experiences of off label prescribing among hospital based paediatricians Pharmacokinetic and pharmacodynamic data collection in children and neonates. A quiet frontier Oral antihypertensive trial design and analysis under the pediatric exclusivity provision Impact of developmental pharmacology on pediatric study design: overcoming the challenges The Newborn Drug Development Initiative Off licence and off label prescribing in children: litigation fears for physicians The cost-effectiveness of orphan drugs Healthy children as subjects in pharmaceutical research Paediatric labelling requirements. Implications for pharmacokinetic studies Salty broth for salicylate poisoning? Adequacy of overdose management advice in the 2001 Compendium of Pharmaceuticals and Specialties
author name string	wds:Q81209124-0356803D-C525-435A-9806-DD42200FF0C6 wds:Q81209124-4D263AD4-0CEA-427D-8529-0F836D17118B
author name string	Christopher S Parshuram Navjeet K Uppal
rdfs:label	Documentation of pediatric drug safety in manufacturers' product monographs: a cross-sectional evaluation of the canadian compendium of pharmaceuticals and specialities (en) Documentation of pediatric drug safety in manufacturers' product monographs: a cross-sectional evaluation of the canadian compendium of pharmaceuticals and specialities (nl) Documentation of pediatric drug safety in manufacturers' product monographs: a cross-sectional evaluation of the canadian compendium of pharmaceuticals and specialities (sq)
skos:prefLabel	Documentation of pediatric drug safety in manufacturers' product monographs: a cross-sectional evaluation of the canadian compendium of pharmaceuticals and specialities (en) Documentation of pediatric drug safety in manufacturers' product monographs: a cross-sectional evaluation of the canadian compendium of pharmaceuticals and specialities (nl) Documentation of pediatric drug safety in manufacturers' product monographs: a cross-sectional evaluation of the canadian compendium of pharmaceuticals and specialities (sq)
name	Documentation of pediatric drug safety in manufacturers' product monographs: a cross-sectional evaluation of the canadian compendium of pharmaceuticals and specialities (en) Documentation of pediatric drug safety in manufacturers' product monographs: a cross-sectional evaluation of the canadian compendium of pharmaceuticals and specialities (nl) Documentation of pediatric drug safety in manufacturers' product monographs: a cross-sectional evaluation of the canadian compendium of pharmaceuticals and specialities (sq)
author	wds:Q81209124-F26E1CB6-ABC1-4295-9684-21A9DBB52EAC
author	L Lee Dupuis
title	wds:Q81209124-2038EC82-0BE7-4B3A-81A8-A40F8E55A615
title	Documentation of pediatric drug safety in manufacturers' product monographs: a cross-sectional evaluation of the canadian compendium of pharmaceuticals and specialities (en)
page(s)	wds:Q81209124-2927650C-0D84-4018-88E6-426A0FA6F326
page(s)	193-197
instance of	wds:Q81209124-352F06B6-EE74-4736-935F-11FB67DCA9D9
instance of	scholarly article
PubMed ID	wds:Q81209124-753C2556-D3D7-4E62-B9FD-9B21A8A65DD4
PubMed ID	http://rdf.ncbi.nlm.nih.gov/pubchem/reference/18454571
PubMed ID	18454571
published in	wds:Q81209124-E616147C-C335-41B4-A7AC-C6DC0B4BE502
published in	Pediatric Drugs
issue	wds:Q81209124-037B1051-A9E0-417E-99E9-2A92C827DCB7
volume	wds:Q81209124-47CAD1D9-FA9D-4382-80BB-AB7DD6282988
issue	3
volume	10
DOI	wds:Q81209124-E6FDC079-B087-451B-AB85-F09145723E9F
DOI	http://dx.doi.org/10.2165/00148581-200810030-00007
DOI	10.2165/00148581-200810030-00007
Dimensions Publication ID	wds:Q81209124-2F01536D-F04E-4BAD-9F22-6E9ED8D5A558
Dimensions Publication ID	1004327272
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q81209124
is cites work of	Safety and transparency of pediatric drug trials Drug formulations that require less than 0.1 mL of stock solution to prepare doses for infants and children A Comprehensive List of Items to be Included on a Pediatric Drug Monograph Pharmacotherapy in pediatric critical illness: a prospective observational study
is cites work of	wds:Q34634161-4F275F51-DCA3-498C-B548-08349D21D0C9 wds:Q37472770-1B67C9C3-B9D9-44DB-BCEB-1D9C982E9897 wds:Q43282031-9F103541-19E0-4F10-A066-81FFBC9432B3 wds:Q37686602-BCC97C9B-EE7D-4FDF-811D-8B9B59900D87

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 188 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software